Internal Medicine · Astoria, NY
NPI
1427044023
Since 2005
Specialty
Internal Medicine
Code 174400000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
3044 29th St, Suite 1j
Astoria, NY, 11102
Phone (718) 652-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
416 services
Medicare patients, 2024
274
Average age 74
Drug cost, 2024
$2.3M
3,581 prescriptions
Company payments, 2025
$595
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raja G Ogirala was code 99214 (office e&m - established), 266 times for 197 patients. In total Raja G Ogirala billed 416 services in 7 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 266 | 197 | $64.51 | $17K |
| 99214 Office E&M - Established | Office | 49 | 43 | $106.99 | $5,242 |
| 99213 Office E&M - Established | Facility | 35 | 31 | $49.87 | $1,745 |
| 99213 Office E&M - Established | Office | 29 | 22 | $81.34 | $2,359 |
| 99204 Office E&M - New | Facility | 25 | 25 | $81.62 | $2,041 |
By year: 2022 $39K for 529 services; 2023 $40K for 495 services; 2024 $29K for 416 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raja G Ogirala prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 617 prescriptions and refills. In total Raja G Ogirala wrote 3,581 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 617 | 751 | 130 | $469K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 284 | 339 | 95 | $9,439 |
| Montelukast Sodium Generic | 255 | 586 | 68 | $3,135 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 179 | 313 | 58 | $182K |
| Spiriva Respimat Tiotropium Bromide | 168 | 355 | 48 | $177K |
| Prednisone Generic | 135 | 176 | 78 | $401 |
| Incruse Ellipta Umeclidinium Bromide | 121 | 177 | 38 | $60K |
| Amlodipine Besylate Generic | 86 | 204 | 20 | $425 |
| Rosuvastatin Calcium Generic | 77 | 227 | 26 | $636 |
| Azithromycin Generic | 76 | 137 | 24 | $674 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 76 | 124 | 20 | $56K |
| Losartan Potassium Generic | 73 | 183 | 19 | $495 |
| Breo Ellipta Fluticasone/Vilanterol | 69 | 84 | 14 | $32K |
| Ropinirole Hcl Generic | 64 | 167 | 21 | $785 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 58 | 110 | 14 | $51K |
Brand drugs: 1,824 claims; generic drugs: 1,757 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raja G Ogirala $595 ($595 in general payments such as food, travel and fees) from 12 companies. The largest payer was GlaxoSmithKline, LLC. with $101.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 5 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $96.51 |
| Insmed, Inc. INSM | 4 | $88.63 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $72.85 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $43.01 |
| Grifols USA, LLC | 2 | $41.56 |
| Verona Pharma, Inc. VRNA | 1 | $31.28 |
| Mallinckrodt Hospital Products Inc. | 1 | $30.4 |
| Amgen Inc. AMGN | 1 | $27.72 |
| Merck Sharp & Dohme LLC MRK | 1 | $22.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.